Authors: van Schaik, RHN de Wildt, SN Brosens, R van Fessem, M van den Anker, JN Lindemans, J

Citation: Rhn. Van Schaik et al., The CYP3A43 allele: Is it really rare?, CLIN CHEM, 47(6), 2001, pp. 1104-1106

Authors: van Schaik, RHN de Wildt, SN van Iperen, NM Uitterlinden, AG van den Anker, JN Lindemans, J

Citation: Rhn. Van Schaik et al., CYP3A4-V polymorphism detection by PCR-restriction fragment length polymorphism analysis and its allelic frequency among 199 Dutch Caucasians, CLIN CHEM, 46(11), 2000, pp. 1834-1836

Authors: van Schaik, RHN Wierikx, CDJ Timmerman, MA Oomen, MH van Weerden, WM van der Kwast, TH van Steenbrugge, GJ de Jong, FH

Citation: Rhn. Van Schaik et al., Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues, BR J CANC, 82(1), 2000, pp. 112-117

Authors: Griffioen, PH Zwang, L van Schaik, RHN Engel, H Lindemans, J Cobbaert, CM

Citation: Ph. Griffioen et al., Optimization of apolipoprotein(a) genotyping with pulsed field gel electrophoresis, CLIN CHEM, 45(6), 1999, pp. 771-776

Authors: Engelse, MA Neele, JM van Achterberg, TAE van Aken, BE van Schaik, RHN Pannekoek, H de Vries, CJM

Citation: Ma. Engelse et al., Human activin-A is expressed in the atherosclerotic lesion and promotes the contractile phenotype of smooth muscle cells, CIRCUL RES, 85(10), 1999, pp. 931-939